knowledge -WSS

knowledge

author：focus 2025-09-06 03:33:10 - browse：2

ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that works by blocking the novel — and very buzzworthy — protein target called TIGIT.

The tumor-shrinking activity of the company’s drug, called EOS-448, was minimal but still comparable to early study data from competing TIGIT-targeted drugs in development, including ones from Roche and Merck.

iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Neuroscience startup Neumora files for IPO

WSS

Study finds new variant for Parkinson’s in African populations

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

What AAP's gender

CDC advisory panel says seniors 'may' get RSV vaccine

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

New air purifier tech could be key to improving indoor air quality

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

How one medical school became remarkably diverse

Princess Kate attends Wimbledon with Roger Federer: See the photos

Sports medicine is finally prioritizing gender equality

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

How one medical school became remarkably diverse

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

As pharma fights Medicare drug negotiation, hospitals, docs silent

entertainment

Radiation, mainstay of cancer treatment, begins a fade

As pharma fights Medicare drug negotiation, hospitals, docs silent

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Medicare explains how it will choose drugs for negotiation

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

How a symptom of dementia informs our understanding of creativity

focus

focus

hotspot

leisure time